<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38017426</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>28</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Identifying patterns of reported findings on long-term cardiac complications of COVID-19: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>468</StartPage><MedlinePgn>468</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">468</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-023-03162-5</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Prior reviews synthesized findings of studies on long-term cardiac complications of COVID-19. However, the reporting and methodological quality of these studies has not been systematically evaluated. Here, we conducted a systematic review and meta-analysis on long-term cardiac complications of COVID-19 and examined patterns of reported findings by study quality and characteristics.</AbstractText><AbstractText Label="METHODS">We searched for studies examining long-term cardiac complications of COVID-19 that persisted for 4&#xa0;weeks and over. A customized Newcastle-Ottawa scale (NOS) was used to evaluate the quality of included studies. Meta-analysis was performed to generate prevalence estimates of long-term cardiac complications across studies. Stratified analyses were further conducted to examine the prevalence of each complication by study quality and characteristics. The GRADE approach was used to determine the level of evidence for complications included in the meta-analysis.</AbstractText><AbstractText Label="RESULTS">A total number of 150 studies describing 57 long-term cardiac complications were included in this review, and 137 studies reporting 17 complications were included in the meta-analysis. Only 25.3% (n&#x2009;=&#x2009;38) of studies were of high quality based on the NOS quality assessment. Chest pain and arrhythmia were the most widely examined long-term complications. When disregarding study quality and characteristics, summary prevalence estimates for chest and arrhythmia were 9.79% (95% CI 7.24-13.11) and 8.22% (95% CI 6.46-10.40), respectively. However, stratified analyses showed that studies with low-quality scores, small sample sizes, unsystematic sampling methods, and cross-sectional design were more likely to report a higher prevalence of complications. For example, the prevalence of chest pain was 22.17% (95% CI 14.40-32.55), 11.08% (95% CI 8.65-14.09), and 3.89% (95% CI 2.49-6.03) in studies of low, medium, and high quality, respectively. Similar patterns were observed for arrhythmia and other less examined long-term cardiac complications.</AbstractText><AbstractText Label="CONCLUSION">There is a wide spectrum of long-term cardiac complications of COVID-19. Reported findings from previous studies are strongly related to study quality, sample sizes, sampling methods, and designs, underscoring the need for high-quality epidemiologic studies to characterize these complications and understand their etiology.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Guo</LastName><ForeName>Boya</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Chenya</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Mike Z</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senter</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhenwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, Boston University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Global Public Health, New York University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Song</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Washington Medical Center, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitzpatrick</LastName><ForeName>Annette L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindstr&#xf6;m</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stebbins</LastName><ForeName>Rebecca C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Social, Genetic, &amp; Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noppert</LastName><ForeName>Grace A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Institute for Social Research, University of Michigan, Ann Arbor, MI, 48104, USA. gnoppert@umich.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chihua</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0933-8425</Identifier><AffiliationInfo><Affiliation>Institute for Social Research, University of Michigan, Ann Arbor, MI, 48104, USA. chihuali@umich.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA. chihuali@umich.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. chihuali@umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R00 AG062749</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HD049311</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00AG062749</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AG075719</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2023 Jan 17:2023.01.16.23284620. doi: 10.1101/2023.01.16.23284620</RefSource><PMID Version="1">36711624</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002637" MajorTopicYN="N">Chest Pain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 sequelae</Keyword><Keyword MajorTopicYN="N">Cardiac complications</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>0</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38017426</ArticleId><ArticleId IdType="pmc">PMC10685580</ArticleId><ArticleId IdType="doi">10.1186/s12916-023-03162-5</ArticleId><ArticleId IdType="pii">10.1186/s12916-023-03162-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324(22):2251&#x2013;2252. doi: 10.1001/jama.2020.22717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Post-COVID Conditions. Centers for Disease Control and Prevention. Published June 17, 2022. Accessed July 3, 2022. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html. Accessed 3 Jul 2022.</Citation></Reference><Reference><Citation>Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardiol. 2022;19(5):332&#x2013;341. doi: 10.1038/s41569-021-00631-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00631-3</ArticleId><ArticleId IdType="pmc">PMC8532434</ArticleId><ArticleId IdType="pubmed">34686843</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezel-Potts E, Douiri A, Sun X, Chowienczyk PJ, Shah AM, Gulliford MC. Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK. PLoS Med. 2022;19(7):e1004052. doi: 10.1371/journal.pmed.1004052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004052</ArticleId><ArticleId IdType="pmc">PMC9295991</ArticleId><ArticleId IdType="pubmed">35853019</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Wang CY, Wang SI, Wei JCC. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. eClinicalMedicine. 2022;53. 10.1016/j.eclinm.2022.101619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9366236</ArticleId><ArticleId IdType="pubmed">35971425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M, Koyanagi A, Banitalebi E, et al. The effect of SARS-CoV-2 infection on cardiac function in post-COVID-19 survivors: a systematic review and meta-analysis. J Med Virol. 2023;95(1):e28325. doi: 10.1002/jmv.28325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28325</ArticleId><ArticleId IdType="pubmed">36401352</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha AB, Mehta A, Pokharel P, et al. Long COVID syndrome and cardiovascular manifestations: a systematic review and meta-analysis. Diagnostics (Basel) 2023;13(3):491. doi: 10.3390/diagnostics13030491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13030491</ArticleId><ArticleId IdType="pmc">PMC9913936</ArticleId><ArticleId IdType="pubmed">36766599</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666&#x2013;1687. doi: 10.1093/cvr/cvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrani RD, Dabas N, Goldberger JJ. COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020;17(11):1984&#x2013;1990. doi: 10.1016/j.hrthm.2020.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.06.026</ArticleId><ArticleId IdType="pmc">PMC7319645</ArticleId><ArticleId IdType="pubmed">32599178</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MK, Zidar DA, Bristow MR, et al. COVID-19 and cardiovascular disease: from bench to bedside. Circ Res. 2021;128(8):1214&#x2013;1236. doi: 10.1161/CIRCRESAHA.121.317997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.317997</ArticleId><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Cao L, Zhang Z, et al. Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping. J Clin Epidemiol. 2021;135:17&#x2013;28. doi: 10.1016/j.jclinepi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC8313077</ArticleId><ArticleId IdType="pubmed">33657455</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Shi Q, Zheng P, et al. Assessment of the quality of systematic reviews on COVID-19: a comparative study of previous coronavirus outbreaks. J Med Virol. 2020;92(7):883&#x2013;890. doi: 10.1002/jmv.25901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25901</ArticleId><ArticleId IdType="pmc">PMC7264505</ArticleId><ArticleId IdType="pubmed">32301508</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn TJ, Burton JK, Carter B, et al. Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Med. 2021;19(1):46. doi: 10.1186/s12916-021-01920-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01920-x</ArticleId><ArticleId IdType="pmc">PMC7899793</ArticleId><ArticleId IdType="pubmed">33618741</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung RG, Di Santo P, Clifford C, et al. Methodological quality of COVID-19 clinical research. Nat Commun. 2021;12(1):943. doi: 10.1038/s41467-021-21220-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21220-5</ArticleId><ArticleId IdType="pmc">PMC7878793</ArticleId><ArticleId IdType="pubmed">33574258</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmonds M, Elliott JH, Synnot A, Turner T. Living systematic reviews. Methods Mol Biol. 2022;2345:121&#x2013;134. doi: 10.1007/978-1-0716-1566-9_7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-1566-9_7</ArticleId><ArticleId IdType="pubmed">34550587</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Veritas Health Innovation. Covidence systematic review software. www.covidence.org. Accessed 10 Oct 2023.</Citation></Reference><Reference><Citation>Wells G, Shea B, O&#x2019;Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 10 Oct 2023.</Citation></Reference><Reference><Citation>Balduzzi S, R&#xfc;cker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. BMJ Ment Health. 2019;22(4):153&#x2013;160. doi: 10.1136/ebmental-2019-300117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2019-300117</ArticleId><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>Duval S, Tweedie R. Trim and fill: a simple funnel-plot&#x2013;based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455&#x2013;463. doi: 10.1111/j.0006-341X.2000.00455.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0006-341X.2000.00455.x</ArticleId><ArticleId IdType="pubmed">10877304</ArticleId></ArticleIdList></Reference><Reference><Citation>Balshem H, Helfand M, Sch&#xfc;nemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401&#x2013;406. doi: 10.1016/j.jclinepi.2010.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.07.015</ArticleId><ArticleId IdType="pubmed">21208779</ArticleId></ArticleIdList></Reference><Reference><Citation>H. Sch&#xfc;nemann, J. Brozek, A. Oxman (Eds.), Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach.. Version 3.2 [updated October 2013], The GRADE Working Group (2009). Available from: https://gdt.gradepro.org/app/handbook/handbook.html.Accessed 10 Oct 2023.</Citation></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its Management. Int J Biol Sci. 2022;18(12):4768&#x2013;4780. doi: 10.7150/ijbs.75056.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan. China JAMA Cardiol. 2020;5(7):802&#x2013;810. doi: 10.1001/jamacardio.2020.0950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei JF, Huang FY, Xiong TY, et al. Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis. Heart. 2020;106(15):1154&#x2013;1159. doi: 10.1136/heartjnl-2020-317007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317007</ArticleId><ArticleId IdType="pmc">PMC7398466</ArticleId><ArticleId IdType="pubmed">32354798</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Special article - acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog Cardiovasc Dis. 2020;63(5):682&#x2013;689. doi: 10.1016/j.pcad.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7274977</ArticleId><ArticleId IdType="pubmed">32512122</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(7):811. doi: 10.1001/jamacardio.2020.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Parodi JB, Indavere A, Bobadilla Jacob P, et al. Impact of COVID-19 vaccination in post-COVID cardiac complications. Vaccine. 2023;41(8):1524&#x2013;1528. doi: 10.1016/j.vaccine.2023.01.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.01.052</ArticleId><ArticleId IdType="pmc">PMC9885297</ArticleId><ArticleId IdType="pubmed">36725436</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>